AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ATR · NYSE · Medical - Instruments & Supplies

AptarGroup (ATR)

Designs dispensing, drug-delivery, closure, and material-science solutions.

$124.83

vs last close+1.43 (+1.16%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	893	838	915	910	909	848	887	966	961	963	983	1,027
Cost of revenue	567	526	583	567	559	519	617	669	673	701	707	741
Gross profit	326	312	333	343	351	329	271	297	288	262	276	286
	207	228	221	217	212	209	155	151	149	151	168	158
Research & development	0	93	0	0	0	0	0	0	0	0	168	158
Selling, general & administrative	138	138	153	149	142	139	155	151	149	151	168	168
Other expenses	69	−3	68	67	71	71	0	0	0	0	−168	−168
Operating income	119	84	112	126	138	120	115	146	139	111	109	128
	−9	−4	−8	−8	−7	−4	−9	−6	15	−19	−15	−13
Interest income	1	2	3	3	3	3	3	2	2	5	4	3
Interest expense	10	11	10	10	12	11	11	11	14	17	17	16
Other non-operating income	−1	−7	−2	−2	−5	−7	−2	−5	−29	2	−2	0
Income before tax	110	81	104	118	131	116	106	140	154	92	94	115
Income tax expense	26	18	21	28	31	15	27	28	26	17	21	27
Net income from continuing operations	84	62	83	90	100	101	79	112	128	74	73	88
Net income	84	62	83	90	100	101	79	112	128	74	73	88
EPS, basic	$1.28	$0.95	$1.26	$1.36	$1.51	$1.52	$1.19	$1.69	$1.95	$1.14	$1.13	$1.38
EPS, diluted	$1.26	$0.93	$1.23	$1.34	$1.48	$1.49	$1.17	$1.67	$1.92	$1.13	$1.12	$1.36
Weighted average shares, basic	66	66	66	66	66	67	66	66	66	65	64	64
Weighted average shares, diluted	67	67	67	68	68	68	67	67	67	66	65	65
EBITDA	183	156	179	193	210	195	183	220	243	185	186	208
Depreciation & amortization	63	64	64	65	67	67	66	70	75	77	76	80
EBIT	120	91	114	128	143	127	117	151	168	109	111	128